National trends in the outpatient treatment of anxiety disorders

Journal of Clinical Psychiatry

Volumn 65, Issue 9, 2004, Pages 1166-1173

  Olfson, Mark ^c   Marcus, Steven C ^a   Wan, George J ^b   Geissler, Erika C ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PFIZER INC   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH CARE COST; HEALTH SERVICES RESEARCH; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOTHERAPY; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; FEMALE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; UNITED STATES; UTILIZATION REVIEW;

EID: 5444220072     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0903     Document Type: Article

References (45)

1. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area Prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94 (Pubitemid 23059313)
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19 (Pubitemid 24028993)
3. Kessler RC, DuPont RL, Berglund P, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999;156:1915-1923
4. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000;157:669-682 (Pubitemid 30249642)
5. Woodward LJ, Fergusson DM. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 2001;40:1086-1093 (Pubitemid 32803822)
6. Kushner MG, Abrky LD, Abrams K, et al. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev 2000;20:149-171 (Pubitemid 30100430)
7. Kubzansky LD, Kawachi I, Weiss ST, et al. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998;20:47-58 (Pubitemid 29071466)
8. Allgulander C. Suicide and mortality patterns in anxiety neurosis and depressive neurosis. Arch Gen Psychiatry 1994;51:708-712 (Pubitemid 24281781)
9. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427-435 (Pubitemid 29369796)
10. Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998;173(suppl 34):4-9 (Pubitemid 28312191)
11. Kessler RC, Zhao S, Katz SJ, et al. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry 1999;156:115-123 (Pubitemid 29034888)
12. Narrow WE, Regier DA, Rae DS, et al. Use of services by persons with mental and addictive disorders: findings from the National Institute of Mental Health Epidemiologic Catchment Area program. Arch Gen Psychiatry 1993;50:95-107 (Pubitemid 23059314)
13. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001;58:55-61 (Pubitemid 32057765)
14. Olfson M, Shea S, Feder A, et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med 2000;9:876-883 (Pubitemid 30800023)
15. Olfson M, Broadhead WE, Weissman MM, et al. Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996;53:880-886 (Pubitemid 26357174)
16. Shear MK, Greeno C, Kang J, et al. Diagnosis of nonpsychotic patients in community clinics. Am J Psychiatry 2000;157:581-587 (Pubitemid 30191197)
17. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Panic Disorder. Am J Psychiatry 1998;155(suppl 5):1-34 (Pubitemid 28211237)
18. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2001;62(suppl 11):53-58 (Pubitemid 32537578)
19. Schneier FR. Treatment of social phobia with antidepressants. J Clin Psychiatry 2001;62 (suppl 1):43-48 (Pubitemid 32109724)
20. Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry 1997;58 (suppl 12):18-22 (Pubitemid 27516506)
21. Mathew SJ, Coplan JD, Gorman JM. Management of treatment-refractory panic disorder. Psychopharmacol Bull 2001;35:97-110
22. Sramek JJ, Zarotsky V, Cutler NR. Generalised anxiety disorder: treatment options. Drugs 2002;62:1635-1648 (Pubitemid 34848371)
23. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001;69:875-899 (Pubitemid 33140488)
24. Harman JS, Rollman BL, Hanusa BH, et al. Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med 2002;17:165-172
25. Skaer TL, Robison LM, Sclar DA, et al. Anxiety disorders in the USA, 1990 to 1997: trend in complaint, diagnosis, use of pharmacotherapy and diagnosis of comorbid depression. Pharmacoepidemiol 2000;20:255-265
26. Edwards WS, Berlin M. National Medical Expenditure Survey: questionnaires and data collection methods for the household survey and survey of American Indians and Alaska Natives. Washington, DC: US Dept Health Human Services; 1989. DHHS publication (PHS) 89-3450
27. Cohen SB. Sample design of the 1999 Medical Expenditure Panel Survey Household Component. Rockville, Md: Agency for Healthcare Research and Quality; 2000. MEPS Methodology Report No. 11. AHRQ publication 01-10001
28. Cohen S, DiGaetano R, Waksberg J. Sample design of the 1987 Household Survey, National Medical Expenditure Survey Methods 3. Rockville, Md: Agency for Healthcare Policy and Research; 1991. AHCPR publication 91-10037
29. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Department of Health and Human Services; 1988
30. Physicians' Desk Reference. Montvale, NJ: Medical Economics Co Inc; 1999
31. Shah BV, Barnwell BG, Dieler GS. SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC: Research Triangle Institute; 1997
32. Olfson M, Guardino M, Straening E, et al. Barriers to the treatment of social anxiety. Am J Psychiatry 2000;157:521-527 (Pubitemid 30191190)
33. Kramer ML, Ross J, Davidson JR. Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. J Nerv Ment Dis 2001;189:328-331 (Pubitemid 32448658)
34. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 Study. JAMA 1994;272:1749-1756 (Pubitemid 24372002)
35. Leon AC, Olfson M, Weissman MM, et al. Brief screens for mental disorders in primary care. J Gen Intern Med 1996;11:426-430 (Pubitemid 26286785)
36. Eaton WW, Kessler RC, Wittchen HU, et al. Panic and panic disorder in the United States. Am J Psychiatry 1994;151:413-420 (Pubitemid 24081463)
37. Kessler RC, Foster CL, Saunders WB, et al Social consequences of psychiatric disorders, 1: educational attainment. Am J Psychiatry 1995;152:1026-1032
38. Uhlenhuth EH, Balter MB, Ban TA, et al. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications, 6: trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. Depress Anxiety 1999;9:107-116 (Pubitemid 29239573)
39. Uhlenhuth EH, Balter MB, Ban TA, et al. Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol 1999;9(suppl 6):393-398
40. Bennet JA, Moioffer M, Stanton SP, et al. A risk-benefit assessment of pharmacological treatments of panic. Drug Saf 1998;18:419-430 (Pubitemid 28260588)
41. Piper A. Addiction to benzodiazepines: how common? Arch Fam Med 1995;4:964-970
42. Uhlenhuth EH, Balter MB, Ban TA, et al. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications, 4: therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. J Clin Psychopharmacol 1999;19(suppl 2):23-29
43. Nunes EV, McGrath PJ, Quitkin FM. Treatment anxiety in patients with alcoholism. J Clin Psychiatry 1995;56(suppl 2):3-9
44. Lechin F, van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Psychother Psychosom 1996;65:171-182 (Pubitemid 26245488)
45. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-2536 (Pubitemid 30324195)